MGCD-265-analog

Ask supplier a question | View on supplier's website

MGCD-265-analog are structurally related to MGCD-265 (Glesatinib). MGCD-265-analog is an orally bioavailable multi-target tyrosine kinase inhibitor with potential anti-tumor activity.

Supplier	Alfa Cytology
Product #	BC0493
Pricing	1.0 g, 2.0 g, 5.0 g, inquire

Feedback